Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma.
Chang LiuWenling WuMeng XuJinglin MiLongjiang XuRen-Sheng WangPublished in: BioMed research international (2021)
ARGs may be a potential biomarker for HNSCC prognosis, and targeted therapies for FADD and NKX2-3 are possible to be a new strategy of HNSCC treatment.